logo
Select company
Select metric
7.19%Cash to Assets Ratio
VS
Market
47
Sector
17
Industry
7
History
-
$ 23.14Close
$ 5.41 - $ 33.96 52-Week Range
Ticker Information

Ticker

PTHS

Company Name

PELTHOS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PELTHOS THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PTHS - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 822.85K$ 59.17K7.19%
3/31/2025$ 911.18K$ 131.32K14.41%
12/31/2024$ 1.37M$ 513.44K37.5%
9/30/2024$ 2.14M$ 1.25M58.64%
6/30/2024$ 2.6M$ 2.41M92.38%
3/31/2024$ 4.03M$ 3.77M93.52%
12/31/2023$ 96.39K$ 96.39K100%
9/30/2023$ 22.79K$ 22.79K100%
6/30/2023$ 81.89K$ 81.89K100%
3/31/2023$ 48.61K$ 48.61K100%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PELTHOS THERAPEUTICS INC is calculated as follows: CashnEq [ $ 0 ] / Assets [ $ 0 ]
(=) Cash to Assets [ 0% ]

PTHS - Cash to Assets Ratio, Last 5 years

7.19%

Minimum

Jun 30, 2025

100%

Maximum

Dec 31, 2022

73.06%

Average

93.52%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%